7-MORPHOLINO-L,6-NAPHTHYRIDIN-5-YL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS DNA-PK INHIBITOR
The present disclosure provides compounds and methods for inhibiting DNA-dependent protein kinase (DNA-PK). Aspects of the present disclosure also include methods of using the compounds to treat diseases, including, but not limited to, cancer. In certain embodiments, the compounds inhibit DNA-PK and...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HSIEH, Tom Han Hsiao YEE, Leanna PAQUETTE, Jay John ARNS, Stephen Paul OSBORNE, Simon SMYTH, Elliott KYLE, Alastair H MINCHINTON, Andrew I SHIDMOOSSAVEE, Fahimeh S HAMBY, Callum AMBLER, Martin JAQUITH, James Brian TAN, Jason Samuel BAKER, Jennifer H. E SMILJANIC-HURLEY, Ela |
| description | The present disclosure provides compounds and methods for inhibiting DNA-dependent protein kinase (DNA-PK). Aspects of the present disclosure also include methods of using the compounds to treat diseases, including, but not limited to, cancer. In certain embodiments, the compounds inhibit DNA-PK and thus sensitize cancers to therapies such as chemotherapy and radiotherapy. Certain compounds of the present disclosure are in the form of prodrugs that release the DNA-PK inhibitor in hypoxic tissue such as is known to occur in cancers. Aspects of the present disclosure also include methods of using the compounds for repairing a DNA break in a target genomic region or for modifying expression of one or more genes or proteins. Compounds provided are of formula. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4305031A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4305031A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4305031A13</originalsourceid><addsrcrecordid>eNqNyj0KwjAUAOAuDqLe4R3AQEv9mZ_JK3mYJiFJC51KkTiJVur9cfEATt_yrYv3WbQueO0MWyfM_iQsep30EFixFUcxGFAUuMfEPUVAq8BrDC1K6hJLNCBd613kxM5GSJoCuQa6SE1nACMoi8Jfga3mCycXtsXqPj2WvPu5KaChJLXI82vMyzzd8jN_RvKHujyWdYVV_Uf5AqnnN7Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>7-MORPHOLINO-L,6-NAPHTHYRIDIN-5-YL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS DNA-PK INHIBITOR</title><source>esp@cenet</source><creator>HSIEH, Tom Han Hsiao ; YEE, Leanna ; PAQUETTE, Jay John ; ARNS, Stephen Paul ; OSBORNE, Simon ; SMYTH, Elliott ; KYLE, Alastair H ; MINCHINTON, Andrew I ; SHIDMOOSSAVEE, Fahimeh S ; HAMBY, Callum ; AMBLER, Martin ; JAQUITH, James Brian ; TAN, Jason Samuel ; BAKER, Jennifer H. E ; SMILJANIC-HURLEY, Ela</creator><creatorcontrib>HSIEH, Tom Han Hsiao ; YEE, Leanna ; PAQUETTE, Jay John ; ARNS, Stephen Paul ; OSBORNE, Simon ; SMYTH, Elliott ; KYLE, Alastair H ; MINCHINTON, Andrew I ; SHIDMOOSSAVEE, Fahimeh S ; HAMBY, Callum ; AMBLER, Martin ; JAQUITH, James Brian ; TAN, Jason Samuel ; BAKER, Jennifer H. E ; SMILJANIC-HURLEY, Ela</creatorcontrib><description>The present disclosure provides compounds and methods for inhibiting DNA-dependent protein kinase (DNA-PK). Aspects of the present disclosure also include methods of using the compounds to treat diseases, including, but not limited to, cancer. In certain embodiments, the compounds inhibit DNA-PK and thus sensitize cancers to therapies such as chemotherapy and radiotherapy. Certain compounds of the present disclosure are in the form of prodrugs that release the DNA-PK inhibitor in hypoxic tissue such as is known to occur in cancers. Aspects of the present disclosure also include methods of using the compounds for repairing a DNA break in a target genomic region or for modifying expression of one or more genes or proteins. Compounds provided are of formula.</description><language>eng ; fre ; ger</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240117&DB=EPODOC&CC=EP&NR=4305031A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240117&DB=EPODOC&CC=EP&NR=4305031A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HSIEH, Tom Han Hsiao</creatorcontrib><creatorcontrib>YEE, Leanna</creatorcontrib><creatorcontrib>PAQUETTE, Jay John</creatorcontrib><creatorcontrib>ARNS, Stephen Paul</creatorcontrib><creatorcontrib>OSBORNE, Simon</creatorcontrib><creatorcontrib>SMYTH, Elliott</creatorcontrib><creatorcontrib>KYLE, Alastair H</creatorcontrib><creatorcontrib>MINCHINTON, Andrew I</creatorcontrib><creatorcontrib>SHIDMOOSSAVEE, Fahimeh S</creatorcontrib><creatorcontrib>HAMBY, Callum</creatorcontrib><creatorcontrib>AMBLER, Martin</creatorcontrib><creatorcontrib>JAQUITH, James Brian</creatorcontrib><creatorcontrib>TAN, Jason Samuel</creatorcontrib><creatorcontrib>BAKER, Jennifer H. E</creatorcontrib><creatorcontrib>SMILJANIC-HURLEY, Ela</creatorcontrib><title>7-MORPHOLINO-L,6-NAPHTHYRIDIN-5-YL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS DNA-PK INHIBITOR</title><description>The present disclosure provides compounds and methods for inhibiting DNA-dependent protein kinase (DNA-PK). Aspects of the present disclosure also include methods of using the compounds to treat diseases, including, but not limited to, cancer. In certain embodiments, the compounds inhibit DNA-PK and thus sensitize cancers to therapies such as chemotherapy and radiotherapy. Certain compounds of the present disclosure are in the form of prodrugs that release the DNA-PK inhibitor in hypoxic tissue such as is known to occur in cancers. Aspects of the present disclosure also include methods of using the compounds for repairing a DNA break in a target genomic region or for modifying expression of one or more genes or proteins. Compounds provided are of formula.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyj0KwjAUAOAuDqLe4R3AQEv9mZ_JK3mYJiFJC51KkTiJVur9cfEATt_yrYv3WbQueO0MWyfM_iQsep30EFixFUcxGFAUuMfEPUVAq8BrDC1K6hJLNCBd613kxM5GSJoCuQa6SE1nACMoi8Jfga3mCycXtsXqPj2WvPu5KaChJLXI82vMyzzd8jN_RvKHujyWdYVV_Uf5AqnnN7Q</recordid><startdate>20240117</startdate><enddate>20240117</enddate><creator>HSIEH, Tom Han Hsiao</creator><creator>YEE, Leanna</creator><creator>PAQUETTE, Jay John</creator><creator>ARNS, Stephen Paul</creator><creator>OSBORNE, Simon</creator><creator>SMYTH, Elliott</creator><creator>KYLE, Alastair H</creator><creator>MINCHINTON, Andrew I</creator><creator>SHIDMOOSSAVEE, Fahimeh S</creator><creator>HAMBY, Callum</creator><creator>AMBLER, Martin</creator><creator>JAQUITH, James Brian</creator><creator>TAN, Jason Samuel</creator><creator>BAKER, Jennifer H. E</creator><creator>SMILJANIC-HURLEY, Ela</creator><scope>EVB</scope></search><sort><creationdate>20240117</creationdate><title>7-MORPHOLINO-L,6-NAPHTHYRIDIN-5-YL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS DNA-PK INHIBITOR</title><author>HSIEH, Tom Han Hsiao ; YEE, Leanna ; PAQUETTE, Jay John ; ARNS, Stephen Paul ; OSBORNE, Simon ; SMYTH, Elliott ; KYLE, Alastair H ; MINCHINTON, Andrew I ; SHIDMOOSSAVEE, Fahimeh S ; HAMBY, Callum ; AMBLER, Martin ; JAQUITH, James Brian ; TAN, Jason Samuel ; BAKER, Jennifer H. E ; SMILJANIC-HURLEY, Ela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4305031A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>HSIEH, Tom Han Hsiao</creatorcontrib><creatorcontrib>YEE, Leanna</creatorcontrib><creatorcontrib>PAQUETTE, Jay John</creatorcontrib><creatorcontrib>ARNS, Stephen Paul</creatorcontrib><creatorcontrib>OSBORNE, Simon</creatorcontrib><creatorcontrib>SMYTH, Elliott</creatorcontrib><creatorcontrib>KYLE, Alastair H</creatorcontrib><creatorcontrib>MINCHINTON, Andrew I</creatorcontrib><creatorcontrib>SHIDMOOSSAVEE, Fahimeh S</creatorcontrib><creatorcontrib>HAMBY, Callum</creatorcontrib><creatorcontrib>AMBLER, Martin</creatorcontrib><creatorcontrib>JAQUITH, James Brian</creatorcontrib><creatorcontrib>TAN, Jason Samuel</creatorcontrib><creatorcontrib>BAKER, Jennifer H. E</creatorcontrib><creatorcontrib>SMILJANIC-HURLEY, Ela</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HSIEH, Tom Han Hsiao</au><au>YEE, Leanna</au><au>PAQUETTE, Jay John</au><au>ARNS, Stephen Paul</au><au>OSBORNE, Simon</au><au>SMYTH, Elliott</au><au>KYLE, Alastair H</au><au>MINCHINTON, Andrew I</au><au>SHIDMOOSSAVEE, Fahimeh S</au><au>HAMBY, Callum</au><au>AMBLER, Martin</au><au>JAQUITH, James Brian</au><au>TAN, Jason Samuel</au><au>BAKER, Jennifer H. E</au><au>SMILJANIC-HURLEY, Ela</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>7-MORPHOLINO-L,6-NAPHTHYRIDIN-5-YL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS DNA-PK INHIBITOR</title><date>2024-01-17</date><risdate>2024</risdate><abstract>The present disclosure provides compounds and methods for inhibiting DNA-dependent protein kinase (DNA-PK). Aspects of the present disclosure also include methods of using the compounds to treat diseases, including, but not limited to, cancer. In certain embodiments, the compounds inhibit DNA-PK and thus sensitize cancers to therapies such as chemotherapy and radiotherapy. Certain compounds of the present disclosure are in the form of prodrugs that release the DNA-PK inhibitor in hypoxic tissue such as is known to occur in cancers. Aspects of the present disclosure also include methods of using the compounds for repairing a DNA break in a target genomic region or for modifying expression of one or more genes or proteins. Compounds provided are of formula.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4305031A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | 7-MORPHOLINO-L,6-NAPHTHYRIDIN-5-YL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF USEFUL AS DNA-PK INHIBITOR |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T04%3A58%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HSIEH,%20Tom%20Han%20Hsiao&rft.date=2024-01-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4305031A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |